CompletedNot Applicable

Dyspnea and Idiopathic Pulmonary Fibrosis

France51 participantsStarted 2021-10-22

Plain-language summary

Longitudinal prospective exploratory study on the evolution of dyspnea, in its sensory and affective dimensions, in patients followed for idiopathic pulmonary fibrosis (IPF), between inclusion and a 6-month evaluation

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * diagnosis of IPF according to ATS/ERS guidelines * dyspnea at rest (VAS ≥ 1) or on exertion (mMRC ≥ 1) Exclusion Criteria: * diffuse interstitial lung disease other than IPF * other significant chronic pathology that may cause dyspnea: chronic obstructive pulmonary disease, asthma, heart failure, anemia, obesity (non-exhaustive list), except for pulmonary hypertension

What they're measuring

Evolution of the sensory and affective components of dyspnea

Timeframe: baseline, 6 months

Trial details

NCT IDNCT04864990

SponsorUniversity Hospital, Lille

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2025-04-07

View on ClinicalTrials.gov More Pulmonary Fibrosis trials